SPOK: Rasio silihan jangka dawa marang modal spok.com

Lambang korporat lan logo USA Mobility (SPOK)

The market valuation dynamics for Spok Holdings, Inc. (SPOK) demonstrate a monopolist position in the hospital wireless communications sector, where a lack of debt and generous shareholder payouts are achieved through 0.02. Revenues are based on stable subscriptions and software products with minimal cost growth. Such a defensive business nature guarantees resilient cash flows regardless of economic fluctuations or consumer demand.

Spok Corp (SPOK) - Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 31.10.2026
Produk asli Spok Holdings Inc

Spok Holdings, Inc. (SPOK) leverages significant pricing power within the critical hospital communications segment to efficiently service its debt, as reflected by the long-term liabilities-to-equity ratio on GURU.Markets. This metric compares long-term loans against shareholder equity to measure financial leverage and determine the sustainability of the asset's funding structure for long-term development planning.

Analisis perusahaan pesaing

Veeva Systems (VEEV) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas DOCS (Doximity Corp)|Rasio silihan jangka dawa marang modal HQY|Waystar Holding Corp. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CRVL|PRVA - Utang jangka dawa marang ekuitas|Huron Consulting Group Inc. (HURN) - Rasio utang jangka dawa marang ekuitas|CERT: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Omnicell Health (OMCL)|GDRX (GoodRx Holdings, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal SDGR (schrodinger.com)|Utang jangka dawa marang ekuitas Phreesia (PHR)|Rasio tanggungan utang jangka dawa marang modal Omada Health, Inc.|Utang jangka dawa marang ekuitas Evolent EVH|HSTM (HealthStream Learning) - Kewajiban jangka dawa marang ekuitas|DH - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal consensus.com|agilon health (AGL) - Utang jangka dawa marang ekuitas|Absci Corp (ABSI) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas SY|NRC: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal OPRX|TBRG (trubridge.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Simulations Plus SLP|Sophia Genetics (SOPH) - Kewajiban jangka dawa marang modal|HCAT - Utang jangka dawa marang ekuitas|CCLD: Utang jangka dawa marang ekuitas|RSSS: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal DLHC|ONMD (OneMedNet Corp) - Utang jangka dawa marang modal|Scienture Holdings (SCNX) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Healthcare Triangle Corp (HCTI)|ispecimen.com - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal BFRG (Bullfrog AI)|Tanggungan utang jangka dawa marang ekuitas scworx.com|MSPR - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal iCoreConnect Inc. ICCT|MEDS (TRxADE) - Rasio utang jangka dawa marang ekuitas|Orgenesis Corporation - Koefisien utang jangka dawa marang modal|RCM (R1 RCM, Inc.) - Utang jangka dawa marang modal|sharecare.com (SHCR) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Streamline Health (STRM)|Syra Health Corp - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal AMEH (Apollo Medical Holdings, Inc.)|MODN - Rasio utang jangka dawa marang ekuitas|NXGN: Rasio utang jangka dawa marang ekuitas